• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性甲状腺乳头状癌中 microRNA 和 mRNA 表达谱的综合分析。

Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.

机构信息

Department of Surgery, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200233, P.R. China.

出版信息

Mol Med Rep. 2013 Nov;8(5):1353-8. doi: 10.3892/mmr.2013.1699. Epub 2013 Sep 24.

DOI:10.3892/mmr.2013.1699
PMID:24064622
Abstract

microRNAs (miRNAs) are involved in the pathogenesis of diverse human cancers through its target genes, including papillary thyroid cancer (PTC). However, there are few studies regarding associations between clinicopathological features of PTC with the expression of specific miRNAs and its potential target genes. In the present study, analysis of miRNA was integrated with mRNA expression profiles in aggressive PTC. miRNA and gene expression arrays were used to identify a subset of differentially expressed miRNAs and mRNAs between aggressive and non-aggressive PTCs. These miRNAs and mRNAs were further validated by qPCR in a cohort of 20 PTCs with extrathyroidal invasion and/or distant metastases, and 20 PTCs with no extrathyroidal invasion. The target of these miRNAs was determined by luciferase reporter and bioinformatic analysis. The miRNA arrays identified 14 upregulated miRNAs and 10 downregulated miRNAs in aggressive compared with non-aggressive PTCs. Significant miRNA deregulation was confirmed in the validation cohort, with upregulation of miR-146b-5p and miR-221/222 and downregulation of miR-16 and miR-613 in aggressive PTCs. The gene arrays identified 2000 differentially expressed genes, in which TIMP3, ZNFR3, FN1 and ITGA2 were observed to be target genes inversely correlated with miR-221/222, miR-146b-5p, miR-613 and miR-16, respectively. The results of the present study indicated the potential importance of miR-221/222, miR-146b-5p, miR-16 and miR-613 in determining the aggressive properties of PTC by targeting TIMP3, ZNFR3, FN1 and ITGA2, respectively. Additional studies should be conducted to confirm the results.

摘要

微小 RNA(miRNAs)通过其靶基因参与多种人类癌症的发病机制,包括甲状腺乳头状癌(PTC)。然而,关于 PTC 的临床病理特征与特定 miRNAs 及其潜在靶基因表达之间的关联的研究较少。在本研究中,miRNA 分析与侵袭性 PTC 的 mRNA 表达谱相结合。使用 miRNA 和基因表达阵列来鉴定侵袭性和非侵袭性 PTC 之间差异表达的 miRNA 和 mRNAs 子集。这些 miRNA 和 mRNAs 在 20 例有甲状腺外侵犯和/或远处转移和 20 例无甲状腺外侵犯的 PTC 患者的队列中通过 qPCR 进一步验证。这些 miRNA 的靶基因通过荧光素酶报告和生物信息学分析确定。miRNA 阵列鉴定出 14 个上调的 miRNA 和 10 个下调的 miRNA 在侵袭性 PTC 中与非侵袭性 PTC 相比。在验证队列中证实了显著的 miRNA 失调,侵袭性 PTC 中 miR-146b-5p 和 miR-221/222 上调,miR-16 和 miR-613 下调。基因阵列鉴定出 2000 个差异表达的基因,其中 TIMP3、ZNFR3、FN1 和 ITGA2 被观察为与 miR-221/222、miR-146b-5p、miR-613 和 miR-16 分别呈负相关的靶基因。本研究的结果表明,miR-221/222、miR-146b-5p、miR-16 和 miR-613 通过靶向 TIMP3、ZNFR3、FN1 和 ITGA2,分别在决定 PTC 的侵袭性方面具有重要意义。应进行更多的研究来证实这些结果。

相似文献

1
Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.侵袭性甲状腺乳头状癌中 microRNA 和 mRNA 表达谱的综合分析。
Mol Med Rep. 2013 Nov;8(5):1353-8. doi: 10.3892/mmr.2013.1699. Epub 2013 Sep 24.
2
MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.微小 RNA 特征可区分甲状腺乳头状癌的侵袭程度。
Ann Surg Oncol. 2011 Jul;18(7):2035-41. doi: 10.1245/s10434-011-1733-0. Epub 2011 May 3.
3
miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.miR-146b 在具有高危特征的成人甲状腺乳头状癌中高度表达,这些特征包括甲状腺外侵犯和 BRAF(V600E)突变。
Thyroid. 2010 May;20(5):489-94. doi: 10.1089/thy.2009.0027.
4
Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?微 RNA 特征能否区分具有不确定恶性潜能的甲状腺肿瘤和其他分化良好的甲状腺肿瘤?
Endocr Relat Cancer. 2011 Sep 13;18(5):579-94. doi: 10.1530/ERC-10-0283. Print 2011 Oct.
5
miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.乳腺癌中的微小RNA表达随淋巴结转移及其他临床病理特征而变化。
IUBMB Life. 2014 May;66(5):371-7. doi: 10.1002/iub.1273. Epub 2014 May 20.
6
MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.微小 RNA miR-146b-5p 通过抑制甲状腺癌细胞中的 SMAD4 来调节 TGF-β 的信号转导。
Oncogene. 2012 Apr 12;31(15):1910-22. doi: 10.1038/onc.2011.381. Epub 2011 Aug 29.
7
Identification of key genes and miRNAs markers of papillary thyroid cancer.鉴定甲状腺乳头状癌的关键基因和 miRNA 标志物。
Biol Res. 2018 Nov 10;51(1):45. doi: 10.1186/s40659-018-0188-1.
8
MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.具有预后潜力的微小 RNA 可用于预测透明细胞肾细胞癌的转移:原发肿瘤与远处转移的比较。
Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3. Epub 2013 Nov 18.
9
Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.鉴别微小 RNA 用于管理甲状腺乳头状癌和具有甲状腺滤泡肿瘤乳头状核特征的非侵袭性肿瘤。
Thyroid. 2018 Mar;28(3):319-327. doi: 10.1089/thy.2017.0127. Epub 2018 Mar 2.
10
Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.miR-146b 表达的预后意义及其在甲状腺乳头状癌中的功能作用。
J Clin Endocrinol Metab. 2013 Feb;98(2):E196-205. doi: 10.1210/jc.2012-2666. Epub 2012 Dec 21.

引用本文的文献

1
Plasma miRNA-146b-3p, -222-3p, -221-5p, -21a-3p Expression Levels and Methylation: Diagnostic Potential and Association with Clinical and Pathological Features in Papillary Thyroid Cancer.血浆 miRNA-146b-3p、-222-3p、-221-5p、-21a-3p 表达水平和甲基化:在甲状腺乳头状癌中的诊断潜力及与临床和病理特征的相关性。
Int J Mol Sci. 2024 Aug 1;25(15):8412. doi: 10.3390/ijms25158412.
2
The diagnostic and prognostic role of miR-146b-5p in differentiated thyroid carcinomas.miR-146b-5p 在分化型甲状腺癌中的诊断和预后作用。
Front Endocrinol (Lausanne). 2024 Jul 5;15:1390743. doi: 10.3389/fendo.2024.1390743. eCollection 2024.
3
Exosomal noncoding RNAs: decoding their role in thyroid cancer progression.
外泌体非编码 RNA:解析其在甲状腺癌进展中的作用。
Front Endocrinol (Lausanne). 2024 Jun 12;15:1337226. doi: 10.3389/fendo.2024.1337226. eCollection 2024.
4
DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma.DLK1-DIO3区域作为甲状腺乳头状癌中肿瘤抑制性微小RNA的来源
Transl Oncol. 2024 Aug;46:101849. doi: 10.1016/j.tranon.2023.101849. Epub 2024 May 31.
5
Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.组织金属蛋白酶抑制剂 3:揭示其在肿瘤学中的生物学功能和意义。
Int J Mol Sci. 2024 Mar 10;25(6):3191. doi: 10.3390/ijms25063191.
6
MicroRNA-96-5p is negatively regulating GPC3 in the metastasis of papillary thyroid cancer.微小RNA-96-5p在甲状腺乳头状癌转移中对GPC3起负调控作用。
SAGE Open Med. 2023 Oct 29;11:20503121231205710. doi: 10.1177/20503121231205710. eCollection 2023.
7
Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer.非编码 RNA 对整合素的调控及其作为癌症治疗靶点的潜力。
Cell Oncol (Dordr). 2023 Apr;46(2):239-250. doi: 10.1007/s13402-022-00752-y. Epub 2022 Dec 13.
8
Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma.甲状腺癌中TIMP3抑癌活性的转录组图谱
Cancer Cell Int. 2022 Dec 12;22(1):400. doi: 10.1186/s12935-022-02811-8.
9
Integrative Analysis of Potential Biomarkers Involved in the Progression of Papillary Thyroid Cancer.甲状腺乳头状癌进展相关潜在生物标志物的综合分析
Appl Biochem Biotechnol. 2023 May;195(5):2917-2932. doi: 10.1007/s12010-022-04244-5. Epub 2022 Nov 29.
10
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers.甲状腺球蛋白测量不可靠患者的甲状腺癌持续存在:循环微小RNA作为候选替代生物标志物
Cancers (Basel). 2022 Nov 16;14(22):5620. doi: 10.3390/cancers14225620.